Trinity biotech Captia (TM) Syphilis IgM Capture Test Kit, Product No./REF 800-935, Test Kit for ...

FDA Device Recall #Z-0819-2015 — Class III — November 17, 2014

Recall Summary

Recall Number Z-0819-2015
Classification Class III — Low risk
Date Initiated November 17, 2014
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Clark Laboratories, Inc. (dba,Trinity Biotech USA)
Location Jamestown, NY
Product Type Devices
Quantity Domestic: 9 kits; Foreign: 26 kits

Product Description

Trinity biotech Captia (TM) Syphilis IgM Capture Test Kit, Product No./REF 800-935, Test Kit for 96 Determinations, IVD for In Vitro Diagnostic use; an antibody class capture enzyme immunoassay for the detection of IgM antibodies to T. pallidum as an aid to the identification of active syphilis in human serum.

Reason for Recall

Through in-house routine real time stability monitoring of Trinity's Captia Syphilis IgM Capture Test Kit, Lot 033, the firm identified a failure of the kit to meet its labeled expiry dating of 6 months.

Distribution Pattern

New York, Florida, Utah, and California plus foreign distribution to Spain and France

Lot / Code Information

Lot 033, expiry date 30 November 2014

Other Recalls from Clark Laboratories, Inc. (dba,Trinity...

Recall # Classification Product Date
Z-0620-2019 Class II ultra2 Genesys Variants Analyzer, REF 03-01-004... Nov 1, 2018
Z-0623-2019 Class II Genesys 2 Reagent, REF 01-03-0022 intended to b... Nov 1, 2018
Z-0621-2019 Class II Genesys Analytical Column, REF 01-05-0017 inten... Nov 1, 2018
Z-0622-2019 Class II Genesys 1 Reagent, REF 01-03-0020 intended to b... Nov 1, 2018
Z-0624-2019 Class II Genesys Diluent Reagent, REF 01-03-0019 intende... Nov 1, 2018

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.